BFSG LLC’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.12K	Hold	1,000	–	–	﹤0.01%	629
2025 Q1	$971	Hold	1,000	–	–	﹤0.01%	631
2024 Q4	$1.17K	Buy	+1,000	New	+$1.17K	﹤0.01%	626